NEW YORK (Reuters) – Eli Lilly and Co forecast 2010 earnings in line with Wall Street expectations, but suggested earnings could fall after its biggest drugs lose patent protection between 2011 and 2014.

Read the rest here:
Lilly suggests profit stumble after patent cliff